Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (12): 1041-1049.doi: 10.35541/cjd.20220609
• Guidelines and Consensus • Previous Articles Next Articles
Centre for Urticaria Research, Chinese Society of Dermatology
Received:
2022-08-30
Revised:
2022-10-14
Online:
2022-12-15
Published:
2022-12-05
Contact:
Xu Jinhua; Hao Fei
E-mail:xjhhsyy@163.com; haofei62@126.com
Supported by:
Centre for Urticaria Research, Chinese Society of Dermatology. Guideline for diagnosis and treatment of urticaria in China (2022)[J]. Chinese Journal of Dermatology, 2022, 55(12): 1041-1049.doi:10.35541/cjd.20220609
[1] | 中华医学会皮肤性病学分会免疫学组. 中国荨麻疹诊疗指南(2014版)[J]. 中华皮肤科杂志, 2014,47(7):514⁃516. |
[2] | 中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南(2018版)[J]. 中华皮肤科杂志, 2019,52(1):1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001. |
[3] | Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria[J]. Allergy, 2022,77(3):734⁃766. doi: 10.1111/all. 15090. |
[4] | 赵作涛. 慢性荨麻疹诊治:现状与展望[J]. 中华皮肤科杂志, 2021,54(12):1105⁃1109. doi: 10.35541/cjd.20210744. |
[5] | Li J, Mao D, Liu S, et al. Epidemiology of urticaria in China: a population⁃based study[J]. Chin Med J (Engl), 2022,135(11):1369⁃1375. doi: 10.1097/CM9.0000000000002172. |
[6] | Zhang L, Qiu L, Wu J, et al. GWAS of chronic spontaneous urticaria reveals genetic overlap with autoimmune diseases, not atopic diseases[J]. J Invest Dermatol, 2022. doi: 10.1016/j.jid.2022.07.012. |
[7] | Maurer M, Taube C, Schröder N, et al. Mast cells drive IgE⁃mediated disease but might be bystanders in many other inflammatory and neoplastic conditions[J]. J Allergy Clin Immunol, 2019,144(4S):S19⁃S30. doi: 10.1016/j.jaci.2019.07.017. |
[8] | Kabashima K, Nakashima C, Nonomura Y, et al. Biomarkers for evaluation of mast cell and basophil activation[J]. Immunol Rev, 2018,282(1):114⁃120. doi: 10.1111/imr.12639. |
[9] | Wedi B, Traidl S. Anti⁃IgE for the treatment of chronic urticaria[J]. Immunotargets Ther, 2021,10:27⁃45. doi: 10.2147/ITT.S26 1416. |
[10] | Belmesk L, Muntyanu A, Cantin E, et al. Prominent role of type 2 immunity in skin diseases: beyond atopic dermatitis[J]. J Cutan Med Surg, 2022,26(1):33⁃49. doi: 10.1177/1203475421 1027858. |
[11] | 朱奕锜, 唐慧, 王朵勤, 等. 维生素D与慢性荨麻疹的研究进展[J]. 国际皮肤性病学杂志, 2017,43(4):223⁃226. doi: 10. 3760/cma.j.issn.1673⁃4173.2017.04.010. |
[12] | Wang D, Tang H, Shen Y, et al. Activation of the blood coagulation system in patients with chronic spontaneous urticaria[J]. Clin Lab, 2015,61(9):1283⁃1288. doi: 10.7754/clin.lab.2015.150226. |
[13] | Kanani A, Betschel SD, Warrington R. Urticaria and angioedema[J]. Allergy Asthma Clin Immunol, 2018,14(Suppl 2):59. doi: 10.1186/s13223⁃018⁃0288⁃z. |
[14] | Davis M, van der Hilst J. Mimickers of urticaria: urticarial vasculitis and autoinflammatory diseases[J]. J Allergy Clin Immunol Pract, 2018,6(4):1162⁃1170. doi: 10.1016/j.jaip.2018. 05.006. |
[15] | 康玉英, 何肖, 刘勇, 等. 急性荨麻疹住院患者185例回顾分析[J]. 中华皮肤科杂志, 2018,51(3):224⁃227. doi: 10.3760/cma.j.issn.0412⁃4030.2018.03.016. |
[16] | Guarneri C, Ceccarelli M, Rinaldi L, et al. Helicobacter pylori and skin disorders: a comprehensive review of the available literature[J]. Eur Rev Med Pharmacol Sci, 2020,24(23):12267⁃12287. doi: 10.26355/eurrev_202012_24019. |
[17] | Zhang L, Qiu L, Wu J, et al. IgE and IgG anti⁃thyroid autoantibodies in Chinese patients with chronic spontaneous urticaria and a literature review[J]. Allergy Asthma Immunol Res, 2022,14(1):131⁃142. doi: 10.4168/aair.2022.14.1.131. |
[18] | 中国医师协会变态反应医师分会, 福棠儿童医学发展研究中心, 北京医师协会变态反应专科医师分会. 过敏原特异性IgE检测结果临床解读中国专家共识[J].中华预防医学杂志,2022,56(6):707⁃725. doi: 10.3760/cma.j.cn112150⁃20220320⁃00263. |
[19] | Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias ⁃ The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision[J]. Allergy, 2016,71(6):780⁃802. doi: 10.1111/all.12884. |
[20] | 陈玉迪, 刘擘, 宋晓婷, 等. 临界温度阈值检测在冷接触性荨麻疹中的临床应用[J]. 中华皮肤科杂志, 2020,53(5):352⁃355. doi: 10.35541/cjd.20190840. |
[21] | 中华医学会皮肤性病学分会荨麻疹研究中心. 慢性荨麻疹患者宣教指南[J]. 中华皮肤科杂志, 2022,e20220305. doi:10. 35541/cjd.20220305. |
[22] | Zhong H, Song Z, Chen W, et al. Chronic urticaria in Chinese population: a hospital⁃based multicenter epidemiological study[J]. Allergy, 2014,69(3):359⁃364. doi: 10.1111/all.12338. |
[23] | Choi GS, Nam YH, Park CS, et al. Anxiety, depression, and stress in Korean patients with chronic urticaria[J]. Korean J Intern Med, 2020,35(6):1507⁃1516. doi: 10.3904/kjim.2019.320. |
[24] | Cataldi M, Maurer M, Taglialatela M, et al. Cardiac safety of second⁃generation H(1) ⁃antihistamines when updosed in chronic spontaneous urticaria[J]. Clin Exp Allergy, 2019,49(12):1615⁃1623. doi: 10.1111/cea.13500. |
[25] | Zhang L, Wu J, Qi Y, et al. Long⁃term combinations and updosing of second⁃generation H1⁃antihistamines show efficacy and safety in the treatment of chronic spontaneous urticaria: a multicenter real⁃life pilot study[J]. J Allergy Clin Immunol Pract, 2020,8(5):1733⁃1736.e11. doi: 10.1016/j.jaip.2019.12. 006. |
[26] | Zhao ZT, Ji CM, Yu WJ, et al. Omalizumab for the treatment of chronic spontaneous urticaria: a meta⁃analysis of randomized clinical trials[J]. J Allergy Clin Immunol, 2016,137(6):1742⁃1750.e4. doi: 10.1016/j.jaci.2015.12.1342. |
[27] | Kocatürk E, Deza G, Kızıltaç K, et al. Omalizumab updosing for better disease control in chronic spontaneous urticaria patients[J]. Int Arch Allergy Immunol, 2018,177(4):360⁃364. doi: 10. 1159/000491530. |
[28] | Kulthanan K, Chaweekulrat P, Komoltri C, et al. Cyclosporine for chronic spontaneous urticaria: a meta⁃analysis and systematic review[J]. J Allergy Clin Immunol Pract, 2018,6(2):586⁃599. doi: 10.1016/j.jaip.2017.07.017. |
[29] | Kessel A, Toubi E. Cyclosporine⁃a in severe chronic urticaria: the option for long⁃term therapy[J]. Allergy, 2010,65(11):1478⁃1482. doi: 10.1111/j.1398⁃9995.2010.02419.x. |
[30] | Liu L, Zhao H, Sun X, et al. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta⁃analysis[J]. BMC Complement Altern Med, 2018,18(1):243. doi: 10.1186/s12906⁃018⁃2305⁃7. |
[31] | Maurer M, Giménez⁃Arnau AM, Sussman G, et al. Ligelizumab for chronic spontaneous urticaria[J]. N Engl J Med, 2019,381(14):1321⁃1332. doi: 10.1056/NEJMoa1900408. |
[32] | Errichetti E, Stinco G. Recalcitrant chronic urticaria treated with dupilumab: report of two instances refractory to H1⁃antihistamines, omalizumab and cyclosporine and brief literature review[J]. Dermatol Ther, 2021,34(2):e14821. doi: 10.1111/dth.14821. |
[33] | Bernstein JA, Singh U, Rao MB, et al. Benralizumab for chronic spontaneous urticaria[J]. N Engl J Med, 2020,383(14):1389⁃1391. doi: 10.1056/NEJMc2016395. |
[34] | Altrichter S, Staubach P, Pasha M, et al. An open⁃label, proof⁃of⁃concept study of lirentelimab for antihistamine⁃resistant chronic spontaneous and inducible urticaria[J]. J Allergy Clin Immunol, 2022,149(5):1683⁃1690.e7. doi: 10.1016/j.jaci.2021.12.772. |
[35] | Metz M, Sussman G, Gagnon R, et al. Fenebrutinib in H(1) antihistamine⁃refractory chronic spontaneous urticaria: a randomized phase 2 trial[J]. Nat Med, 2021,27(11):1961⁃1969. doi: 10. 1038/s41591⁃021⁃01537⁃w. |
[36] | Kaul M, End P, Cabanski M, et al. Remibrutinib (LOU064): a selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial[J]. Clin Transl Sci, 2021,14(5):1756⁃1768. doi: 10.1111/cts.13005. |
[37] | Pezzolo E, Peroni A, Gisondi P, et al. Heat urticaria: a revision of published cases with an update on classification and management[J]. Br J Dermatol, 2016,175(3):473⁃478. doi: 10. 1111/bjd.14543. |
[38] | Maltseva N, Borzova E, Fomina D, et al. Cold urticaria ⁃ what we know and what we do not know[J]. Allergy, 2021,76(4):1077⁃1094. doi: 10.1111/all.14674. |
[39] | Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence[J]. J Allergy Clin Immunol, 2018,141(2):638⁃649. doi: 10.1016/j.jaci.2017.06.032. |
[40] | Namazy J, Cabana MD, Scheuerle AE, et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy[J]. J Allergy Clin Immunol, 2015,135(2):407⁃412. doi: 10.1016/j.jaci.2014.08.025. |
[41] | Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children ⁃ a systematic review on interventions and comorbidities[J]. Pediatr Allergy Immunol, 2018,29(3):303⁃310. doi: 10.1111/pai.12870. |
[42] | Song XT, Chen YD, Yu M, et al. Omalizumab in children and adolescents with chronic urticaria: a 16⁃week real⁃world study[J]. Allergy, 2021,76(4):1271⁃1273. doi: 10.1111/all.14686. |
[43] | Martina E, Damiani G, Grieco T, et al. It is never too late to treat chronic spontaneous urticaria with omalizumab: real⁃life data from a multicenter observational study focusing on elderly patients[J]. Dermatol Ther, 2021,34(2):e14841. doi: 10.1111/dth.14841. |
[44] | 温禾, 姚煦. 抗组胺药在特殊人群中的应用[J]. 中华皮肤科杂志, 2016,49(9):669⁃671. doi: 10.3760/cma.j.issn.0412⁃4030. 2016.09.022. |
[1] | Ren Fenfen, Wang Peng, Zhang Jingzhan, Kang Xiaojing. Network pharmacology-based prediction of potential effective components of traditional Chinese medicine and their molecular mechanisms of action in the anti-angiogenic treatment of Kaposi′s sarcoma [J]. Chinese Journal of Dermatology, 2023, 0(3): 20220140-e20220140. |
[2] | Yang Aimin, Chen Jiangwei, Huang Jiacheng, Cen Ying, Chen Junjie. Treatment of Merkel cell carcinoma [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210536-e20210536. |
[3] | Yang Ji, Xu Xinzhi, Li Ming. Early diagnosis of dermatomyositis and early recognition of visceral injury [J]. Chinese Journal of Dermatology, 2023, 56(2): 161-164. |
[4] | Jia Yuanyuan, Mao Qiuyu, Yang Jingyi, Min Wei. Efficacy of dupilumab in the treatment of moderate and severe atopic dermatitis in the elderly: a clinical observation [J]. Chinese Journal of Dermatology, 2023, 56(2): 125-129. |
[5] | . Correlation between food-specific IgG antibodies and phenotypes of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(2): 130-135. |
[6] | Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology, The Dermatology Branch of Chinese Medical Education Association. Expert consensus on diagnosis and treatment of senile herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(2): 97-104. |
[7] | Chen Qitao, Li Yuqian, Shao Guanghui, Zhu Jing, Zhu Qilin, Li Zhongming, Du Xufeng, Fan Weixin. Erosive pustular dermatosis of the scalp [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210803-e20210803. |
[8] | Li Tingting, Kang Xiaojing. Gut microbiota and immune checkpoint inhibitor treatment of melanoma [J]. Chinese Journal of Dermatology, 2023, 56(2): 177-180. |
[9] | Yu Miao, Song Xiaoting, Liu Bo, Liao Shuanglu, Luan Tingting, Zhao Zuotao. Autologous serum skin test: immunological mechanisms and its associations with clinical features and prognosis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(2): 184-187. |
[10] | Peng Ying, Liu Yi. Medications for the treatment of acne [J]. Chinese Journal of Dermatology, 2023, 56(2): 173-176. |
[11] | Zhao Ying, Zhang Xiaoyan, Chen Lu, Su Yuhua, Ding Yujie, Leng Hong, Ji Jiang. Predictive factors for the efficacy of omalizumab in the treatment of refractory chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(1): 22-28. |
[12] | Du Fangzhi, Zhang Xu, Wang Qianqiu. Monkeypox: clinical manifestations, diagnosis, treatment and follow-up [J]. Chinese Journal of Dermatology, 2023, 56(1): 76-81. |
[13] | Li Wei, Li Zheng . Atopic dermatitis with typical and atypical manifestations [J]. Chinese Journal of Dermatology, 2023, 56(1): 1-4. |
[14] | Lei Jiehao, Hong Weisong, Lin Fuquan, Hu Wenting, Xu Ai′e. In vitro culture of melanocytes from segmental vitiligo-like nevus depigmentosus lesions and its clinical significance [J]. Chinese Journal of Dermatology, 2022, 55(9): 798-802. |
[15] | Lu Nan, Tan Xingyou, Liu Xiang, Niu Lili, Yao Shulan. Association of single nucleotide polymorphisms in microRNAs with the risk of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2022, 55(9): 806-809. |
|